Symptoms
Listings for biosimilar uptake drivers expanded
Amended prescribing information has been released for two biosimilar uptake drivers listed on the Pharmaceutical Benefits Scheme (PBS), as part of the Biosimilar Awareness...
Pharmacists in 2023: Unlocking the opportunity
It’s time for PSA to reveal our vision of the future of pharmacy in Australia.
I am pleased to announce our Pharmacists in 2023...
New research shows strong support for pharmacy vaccinations
Two in three Australians believe pharmacists should be able to administer commonly used vaccines that currently require a doctor’s appointment, new PSA research shows.
The nationwide...
Out of the shadows
Pharmacists are embracing new opportunities to play a greater role in multidisciplinary teams focused on mental health.
Australian Pharmacist spoke with two mental health...
From the president: Medicine safety commitments
PSA will work with government to address the pressing issue of medicine safety.
When it comes to healthcare, use of medicines is arguably the...
From the President: Pharmacists’ support valued during 2021
'I would like to take this opportunity to thank you for your valued support during 2021,' writes PSA National President A/Prof Chris Freeman.
